Isofol Medical AB (publ) (ISOFOL.ST)
ISOFOL.ST Stock Price Chart
Explore Isofol Medical AB (publ) interactive price chart. Choose custom timeframes to analyze ISOFOL.ST price movements and trends.
ISOFOL.ST Company Profile
Discover essential business fundamentals and corporate details for Isofol Medical AB (publ) (ISOFOL.ST) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
4 Apr 2017
Employees
5.00
Website
https://isofolmedical.comCEO
Petter Segelman Lindqvist
Description
Isofol Medical AB (publ), a clinical stage biotech company, develops, commercializes, and sells oncology drugs in Sweden and internationally. The company develops arfolitixorin, which is in phase 3 clinical trial for the treatment of advanced colorectal cancer. It has strategic collaborations with Recipharm, Merck & Cie, and Sahlgrenska University Hospital. The company was incorporated in 2008 and is headquartered in Gothenburg, Sweden.
ISOFOL.ST Financial Timeline
Browse a chronological timeline of Isofol Medical AB (publ) corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 19 May 2026
Upcoming earnings on 17 Feb 2026
Upcoming earnings on 12 Nov 2025
Earnings released on 18 Jul 2025
Earnings released on 21 May 2025
EPS came in at -kr 0.08 .
Earnings released on 19 Feb 2025
EPS came in at -kr 0.08 .
Earnings released on 12 Nov 2024
EPS came in at -kr 0.07 .
Earnings released on 21 Aug 2024
EPS came in at -kr 0.07 .
Earnings released on 8 May 2024
EPS came in at -kr 0.05 .
Earnings released on 20 Feb 2024
EPS came in at -kr 0.06 surpassing the estimated -kr 0.13 by +56.05%.
Earnings released on 10 Nov 2023
EPS came in at -kr 0.04 surpassing the estimated -kr 0.12 by +68.61%, while revenue for the quarter reached -kr 1.00K .
Earnings released on 22 Aug 2023
EPS came in at -kr 0.05 surpassing the estimated -kr 0.15 by +69.91%, while revenue for the quarter reached kr 361.00K .
Earnings released on 3 May 2023
EPS came in at -kr 0.09 surpassing the estimated -kr 0.19 by +52.63%, while revenue for the quarter reached kr 721.00K .
Earnings released on 22 Feb 2023
EPS came in at -kr 0.16 surpassing the estimated -kr 0.48 by +66.67%, while revenue for the quarter reached kr 1.86M , missing expectations by -9.90%.
Earnings released on 11 Nov 2022
EPS came in at -kr 0.20 surpassing the estimated -kr 0.32 by +37.50%, while revenue for the quarter reached kr 2.91M , missing expectations by -16.94%.
Earnings released on 23 Aug 2022
EPS came in at -kr 0.33 falling short of the estimated -kr 0.32 by -3.13%, while revenue for the quarter reached kr 4.03M .
Earnings released on 12 May 2022
EPS came in at -kr 0.30 surpassing the estimated -kr 0.31 by +3.23%, while revenue for the quarter reached kr 4.01M .
Earnings released on 24 Feb 2022
EPS came in at -kr 0.38 falling short of the estimated -kr 0.32 by -18.75%, while revenue for the quarter reached kr 4.71M , missing expectations by -5.90%.
Earnings released on 11 Nov 2021
EPS came in at -kr 0.32 falling short of the estimated -kr 0.28 by -14.29%, while revenue for the quarter reached kr 5.15M .
Earnings released on 24 Aug 2021
EPS came in at -kr 0.48 falling short of the estimated -kr 0.26 by -84.62%, while revenue for the quarter reached kr 7.33M .
Stock split effective on 24 May 2021
Shares were split 253 : 200 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 14 May 2021
EPS came in at -kr 0.40 surpassing the estimated -kr 0.54 by +25.93%, while revenue for the quarter reached kr 5.22M .
Earnings released on 26 Feb 2021
EPS came in at -kr 0.52 matching the estimated -kr 0.52, while revenue for the quarter reached kr 18.68M .
Earnings released on 13 Nov 2020
EPS came in at -kr 0.28 falling short of the estimated kr 0.98 by -128.57%, while revenue for the quarter reached kr 18.44M .
ISOFOL.ST Stock Performance
Access detailed ISOFOL.ST performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.